A Modified Two Stage Phase II Study of Combination Abraxane and Radiation for Stage III Non-Small Cell Lung Cancer.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 30 Apr 2015
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 29 May 2009 New trial record
- 18 May 2009 Company added in the association field and additional lead trial center identified as reported by ClinicalTrials.gov.